Gynecologic Cancer
From the Journals
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
From the Journals
Breastfeeding reduces invasive ovarian cancer risk
Even women who breastfed less than 3 months had an 18% lower risk of invasive ovarian cancer.
Conference Coverage
Combo elicits responses in advanced cervical cancer
Apatinib plus camrelizumab produced responses regardless of PD-L1 expression.
Conference Coverage
Investigators recommend expanding testing for Lynch syndrome
Feature
Conducting cancer trials amid the COVID-19 pandemic
Conference Coverage
Weight loss intervention fails in endometrial cancer survivors
A weight loss intervention was unsuccessful in obese endometrial cancer survivors.
From the Journals
‘Brutal’ plan to restrict palliative radiation during pandemic
New guidelines recommend giving palliative radiotherapy only in oncologic emergencies during the COVID-19 pandemic.
Conference Coverage
Water-only fasting may reduce chemo modifications, hospital admissions
Conference Coverage
Promising efficacy with adavosertib in uterine serous carcinoma
Feature
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.